PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24576038-8	2014	Treatment with fluprostenol or combined fluprostenol/CTGF induced the activity of matrix metalloproteinase 2 (MMP2) in TM cells, whereas treatment with CTGF alone had no effects on MMP2 activity.	fluprostenol	40-52	matrix metallopeptidase 2	Homo sapiens	110-114	
24576038-8	2014	Treatment with fluprostenol or combined fluprostenol/CTGF induced the activity of matrix metalloproteinase 2 (MMP2) in TM cells, whereas treatment with CTGF alone had no effects on MMP2 activity.	fluprostenol	15-27	matrix metallopeptidase 2	Homo sapiens	82-108	
24576038-8	2014	Treatment with fluprostenol or combined fluprostenol/CTGF induced the activity of matrix metalloproteinase 2 (MMP2) in TM cells, whereas treatment with CTGF alone had no effects on MMP2 activity.	fluprostenol	15-27	matrix metallopeptidase 2	Homo sapiens	110-114	
24576038-8	2014	Treatment with fluprostenol or combined fluprostenol/CTGF induced the activity of matrix metalloproteinase 2 (MMP2) in TM cells, whereas treatment with CTGF alone had no effects on MMP2 activity.	fluprostenol	40-52	matrix metallopeptidase 2	Homo sapiens	82-108	
24576038-9	2014	CONCLUSIONS: Fluprostenol blocks the fibrotic effects of CTGF on human TM cells and increases the activity of MMP2.	fluprostenol	13-25	matrix metallopeptidase 2	Homo sapiens	110-114